The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance
- 1 March 2005
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 142 (5), 323
- https://doi.org/10.7326/0003-4819-142-5-200503010-00007
Abstract
This cost-effectiveness analysis estimates that the Diabetes Prevention Program's lifestyle intervention would cost society about $8800 per quality-adjusted life-year saved. The corresponding resul... Background: The Diabetes Prevention Program (DPP) demonstrated that interventions can delay or prevent the development of type 2 diabetes. Objective: To estimate the lifetime cost–utility of the DP...Keywords
This publication has 38 references indexed in Scilit:
- Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.1996
- An Economic Analysis of Captopril in the Treatment of Diabetic NephropathyDiabetes Care, 1996
- The Onset of NIDDM and its Relationship to Clinical Diagnosis in Egyptian AdultsDiabetic Medicine, 1996
- Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban communityNeurology, 1994
- Onset of NIDDM occurs at Least 4–7 yr Before Clinical DiagnosisDiabetes Care, 1992
- The Prevalence and Incidence of Lower Extremity Amputation in a Diabetic PopulationArchives of Internal Medicine, 1992
- How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.1992
- Prevention: the cost-effectiveness of the California Diabetes and Pregnancy Program.American Journal of Public Health, 1992
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985
- Behavior therapy for obesity: A comparative investigation of long-term efficacy.Journal of Consulting and Clinical Psychology, 1977